Keywords: عامل تحریک کننده erythropoiesis; Exercise; Physical fitness; Renal insufficiency; Body composition; Lower extremity; AAS; adjusted activity score; BAL; Stork balance test; BMI; body mass index; CI; confidence interval; CRP; C-reactive protein; ESA; erythropoiesis-stimulating agent; FLEX;
مقالات ISI عامل تحریک کننده erythropoiesis (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل تحریک کننده erythropoiesis; AML; acute myeloid leukemia; CI; confidence interval; CPT; Current Procedural Terminology; DMT; disease-modifying therapy; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration; HCPCS; Healthcare Common Procedure Coding System; HMA; hyp
Keywords: عامل تحریک کننده erythropoiesis; AKI; acute kidney injury; BMI; body mass index; CKD; chronic kidney disease; CMS; Centers for Medicare and Medicaid Services; eGFR; estimated glomerular filtration rate; ESA; erythropoiesis-stimulating agent; ESRD; end-stage renal disease; HR; hazard rati
Keywords: عامل تحریک کننده erythropoiesis; AMC; absolute monocyte count; AML; acute myeloid leukemia; BM; bone marrow; CMML; chronic myelomonocytic leukemia; CPSS; CMML-Specific Prognostic Scoring System; ESA; erythropoiesis-stimulating agent; GFM; Groupe Français des Myélodysplasies; GVHD; graf
Keywords: عامل تحریک کننده erythropoiesis; alloSCT; allogeneic stem cell transplant; AML; acute myeloid leukemia; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration; FISH; fluorescence in situ hybridization; G-CSF; granulocyte colony stimulating factor; HSCT; hematopoietic st
Keywords: عامل تحریک کننده erythropoiesis; BMSD; biomedical system dynamics; ESA; erythropoiesis-stimulating agent; MCAMS; Mayo Clinic Anemia Management System; MCDS; Mayo Clinic Dialysis System;
Keywords: عامل تحریک کننده erythropoiesis; anemia; darbepoetin alfa; erythropoiesis-stimulating agent; hemoglobin; peritoneal dialysis;
Keywords: عامل تحریک کننده erythropoiesis; chemotherapy-induced anemia; darbepoetin; epoetin; erythropoiesis-stimulating agent;
clinical trialFerric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
Keywords: عامل تحریک کننده erythropoiesis; anemia; erythropoiesis-stimulating agent; ferric pyrophosphate citrate; hemodialysis; iror;
Vitamin D, Race, and Risk for Anemia in Children
Keywords: عامل تحریک کننده erythropoiesis; 25(OH)D; 25-Hydroxyvitamin D; BMI; Body mass index; CDC; Centers for Disease Control and Prevention; CKD; Chronic kidney disease; CRP; C-reactive protein; ESA; Erythropoiesis-stimulating agent; GFR; Glomerular filtration rate; Hgb; Hemoglobin; NHANES; Nat
Anemia Management Trends in Hospital-Based Dialysis Centers (HBDCs), 2010 to 2013
Keywords: عامل تحریک کننده erythropoiesis; anemia; erythropoiesis-stimulating agent; hemoglobin; hospital-based dialysis center; iron;
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines
Keywords: عامل تحریک کننده erythropoiesis; Erythropoiesis-stimulating agent; Myelodysplastic syndrome; Guideline adherence; Supportive care; Medicare;
Keywords: عامل تحریک کننده erythropoiesis; Anemia; Erythropoiesis-stimulating agent; Hemodialysis; Hemoglobin; Iron
Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial
Keywords: عامل تحریک کننده erythropoiesis; Anemia; Chronic kidney disease; Erythropoiesis-stimulating agent; Glomerular filtration rate; Type 2 diabetes
Hemoglobin Differences by Race in Children With CKD
Keywords: عامل تحریک کننده erythropoiesis; Kidney disease; hemoglobin; disparity; erythropoiesis-stimulating agent; glomerular filtration rate; generalized gamma;
Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate
Keywords: عامل تحریک کننده erythropoiesis; Adverse Effects of Hepatitis Therapy; Clinical Trial; Liver Disease; Blood Disorders; AE; adverse event; EOT; end of treatment; ESA; erythropoiesis-stimulating agent; Hb; hemoglobin; HCV; hepatitis C virus; IDEAL; Individualized Dosing Efficacy vs Flat Do
Intravenous Iron Versus Erythropoiesis-Stimulating Agents: Friends or Foes in Treating Chronic Kidney Disease Anemia?
Keywords: عامل تحریک کننده erythropoiesis; Transferrin saturation ratio; Erythropoiesis-stimulating agent; Intravenous iron; Ferritin; Inflammation;
Hemoglobin Variability and Hyporesponsiveness: Much Ado About Something or Nothing?
Keywords: عامل تحریک کننده erythropoiesis; Anemia; Chronic kidney disease; Variability; Sensitivity; Hyporesponsiveness; Erythropoiesis-stimulating agent; Iron deficiency;
What Is So Bad About a Hemoglobin Level of 12 to 13 g/dL for Chronic Kidney Disease Patients Anyway?
Keywords: عامل تحریک کننده erythropoiesis; Anemia; Chronic kidney disease; Erythropoiesis-stimulating agent; Iron deficiency;
A Comprehensive Vision for Intravenous Iron Therapy
Keywords: عامل تحریک کننده erythropoiesis; Intravenous iron; erythropoiesis-stimulating agent; serum ferritin; anemia of chronic kidney disease;
Challenge of Effectively Using Erythropoiesis-Stimulating Agents and Intravenous Iron
Keywords: عامل تحریک کننده erythropoiesis; Anemia of chronic kidney disease; intravenous iron; erythropoiesis-stimulating agent;
The Controversy Surrounding Hemoglobin and Erythropoiesis-Stimulating Agents: What Should We Do Now?
Keywords: عامل تحریک کننده erythropoiesis; Intravenous iron; erythropoiesis-stimulating agent; hemoglobin levels; anemia of chronic kidney disease; hemodialysis;
Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Hemodialysis
Keywords: عامل تحریک کننده erythropoiesis; Anemia; thrombocytosis; iron stores; hemodialysis population; erythropoiesis-stimulating agent; malnutrition-inflammation-cachexia syndrome (MICS);
Anemia in the Elderly: How Should We Define It, When Does It Matter, and What Can Be Done?
Keywords: عامل تحریک کننده erythropoiesis; Epo; erythropoietin; ESA; erythropoiesis-stimulating agent; GI; gastrointestinal; MCV; mean corpuscular volume; MDS; myelodysplastic syndrome; NHANES III; Third US National Health and Nutrition Examination Survey; WHO; World Health Organization;
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations of Existing Therapies
Keywords: عامل تحریک کننده erythropoiesis; CHOIR; Correction of Hemoglobin and Outcomes in Renal Insufficiency; CKD; chronic kidney disease; CREATE; Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin Beta; ESA; erythropoiesis-stimulating agent; FDA; Food and Drug Administration;
Once-Every-2-Weeks and Once-Weekly Epoetin Beta Regimens: Equivalency in Hemodialyzed Patients
Keywords: عامل تحریک کننده erythropoiesis; Erythropoiesis-stimulating agent; dosing frequency; hemodialysis (HD); therapeutic equivalence;